Ultimately, IL-2 secretion was rescued when interfering with the PD-1–PD-L1 interaction using a PD-L1-blocking antibody in the presence of CLL-EVs (Figure 5I). This evidence concerns the gene IL2 and B-cell chronic lymphocytic leukemia.